IP Library Granted Patent US 11,999,757
Granted Patent B2
US 11,999,757 · App. 16/760,369 · Granted Jun 4, 2024

Synthesis of boronate ester derivatives and uses thereof

Inventors: Serge Henri Boyer (San Diego, CA); Scott J. Hecker (Del Mar, CA); Gerardus K. M. Verzijl (Well, NL); Petrus J. Hermsen (Horst, NL)
Assignee: MELINTA SUBSIDIARY CORP.
C07F5/025B01J23/462C07C67/31C07C69/675C07F5/04C12P9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,999,757
App. No.
16/760,369
Granted
Jun 4, 2024
Kind
B2
Abstract

Disclosed herein are methods for the preparation of boronate derivatives in the synthesis of antimicrobial compounds and uses thereof. Disclosed herein includes method of making a compound of Formula (B) by reducing the ketone group of the keto-ester compound of Formula (A), and the reduction can be performed using a Ruthenium based catalyst system or using an alcohol dehydrogenase bioreduction system.

Claims (90)

1. A compound having the structure of Formula (I):

wherein X is a halogen and m is 2, 4, 5, or 6.

2. The compound of claim 1 , wherein X is Cl and m is 2.

3. A compound having the structure of Formula (II):

or a salt thereof, wherein:

X is a halogen;

m is an integer between 2 and 6;

each of R 1a and R 1b is independently selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or

R 1a and R 1b together with intervening atoms optionally form a 5-7 membered boron ester ring; and

R 2 is selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl.

4. The compound of claim 3 , wherein Xis Cl and each of R 1a and R 1b is a butyl group.

5. A method of making a compound of Formula (B), comprising the steps of:

reducing the ketone group of a compound of Formula (A):

to form a compound of Formula (B):

wherein:

X is Cl;

m is 2;

the ketone group in the compound of Formula (A) is reduced using Ru(OAc) 2 ((R)-SegPhos) and methanol; and

the compound of Formula (B) is produced in an enantiomeric excess of greater than 99%.

6. A method of making a compound of Formula (B), comprising the steps of:

reducing the ketone group of a compound of Formula (A):

to form a compound of Formula (B):

wherein:

X is Cl;

m is 2; and

the ketone group in the compound of Formula (A) is reduced with an alcohol dehydrogenase system, wherein

the alcohol dehydrogenase system comprises a reduced nicotinamide adenine dinucleotide (NADH), a reduced nicotinamide adenine dinucleotide phosphate (NADPH), and an alcohol,

the alcohol is isopropyl alcohol,

acetone is generated as a by-product,

the acetone is removed under vacuum, and

the compound of Formula (B) is produced in an enantiomeric excess of greater than 99%.

7. A method of making a compound of Formula (C), comprising:

reacting a boronate compound B(OR 4a )(OR 4b )(OR 4c ) with a compound of Formula (B-1):

to form the compound of Formula (C):

wherein:

X is a halogen;

m is an integer between 2 and 6;

R 2 is selected from the group consisting of, an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl;

R 4a and R 4b are independently selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or

R 4a and R 4b together with intervening atoms optionally form a 5-8 membered boron ester ring; and

R 4c is selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl.

8. The method of claim 7 , wherein X is Cl; m is 2; and R 2 , R 4a , and R 4b are each independently a butyl group.

9. A method of making a compound of Formula (D), comprising:

reacting magnesium with a compound of Formula (C):

to form a first reaction intermediate; and

hydrolyzing the first reaction intermediate to form the compound of Formula (D):

wherein:

X is a halogen;

m is an integer between 2 and 6;

R 2 is selected from the group consisting of, an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl; and

each of R 4a and R 4b is independently selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or

R 4a and R 4b together with intervening atoms optionally form a 5-8 membered boron ester ring.

10. The method of claim 9 , wherein Xis Cl; m is 2; and R 2 , R 4a , and R 4b are independently a butyl group.

11. The method of claim 9 , wherein the compound of Formula (D)

12. A method of making a compound of Formula (E), comprising

reducing the ketone group of a keto-ester compound of Formula (A-1):

to form a compound of Formula (B-1):

reacting a boronate compound B(OR 4a )(OR 4b )(OR 4c ) with the compound of Formula (B-1) to form a compound of Formula (C):

reacting magnesium with the compound of Formula (C) to form a first reaction intermediate;

hydrolyzing the first reaction intermediate to form a compound of Formula (D):

and

reacting the compound of Formula (D) with a complexing agent of Formula (CL):

to form the compound of Formula (E):

wherein:

X is a halogen;

m is an integer between 2 and 6;

n is an integer between 0 and 6;

Y 1 is O or N + R 9 R 10 ;

Y 2 is O or NR 11 ;

R 2 is selected from the group consisting of, an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl;

R 4a and R 4b are independently selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or

R 4a and R 4b together with intervening atoms optionally form a 5-8 membered boron ester ring;

R 4c is selected from the group consisting of an optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl;

each R 5 and R 6 is independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl, or R 5 and R 6 together with the atom to which they are attached, form ═O;

each R 7 and R 8 is independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl, or R 5 and R 7 together with the atom to which they are attached form an aryl or heteroaryl ring; or R 7 and R 8 together with the atom to which they are attached, form ═O; and

each R 9 , R 10 and R 11 is independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl.

13. The method of claim 12 , wherein X is Cl, m is 2, and R 2 is a butyl group.

14. The method of claim 12 , wherein the complexing agent of Formula (CL) is NH 2 (CH 2 ) 2 OH.

15. The method of claim 12 , further comprising reacting the compound of Formula (E) with pinanediol to form a compound of Formula (F):

protecting the hydroxy group of the compound of Formula (F) with a PG group to form a compound of Formula (G):

reacting the compound of Formula (G) with n-butyllithium and dichloromethane to form a compound of Formula (H):

reacting the compound of Formula (H) with an LiN[Si(R 12 ) 3 ] 2 to form a compound of Formula (J):

reacting the compound of Formula (J) with R 13 —COCl to form a compound of Formula (K):

and

removing the PG group on the compound of Formula (K) to form a compound of Formula (L):

wherein:

PG is a hydroxy protection group;

R 12 is optionally substituted phenyl or optionally substituted C 1-8 alkyl; and

R 13 is selected from the group consisting of optionally substituted C 1-8 alkyl, optionally substituted C 0-4 alkyl-C 6-10 aryl, optionally substituted C 0-4 alkyl-5-10 membered heteroaryl, optionally substituted C 0-4 alkyl-C 3-10 carbocyclyl, and C 0-4 alkyl-4-10 membered heterocyclyl.

16. The method of claim 15 , wherein R 13 is

Assignments (5)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT (PATENTS) AT REEL 054836 AND FRAME 0765 AND REEL 061314 AND 0459 Recorded Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →
SECURITY INTEREST Recorded Aug 13, 2024
From: MELINTA SUBSIDIARY CORP.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 068260/0283 →
CHANGE OF NAME Recorded Apr 3, 2024
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 066998/0923 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 22, 2020
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 054836/0765 →